Full length ArticlePostural sway as a marker of progression in Parkinson's disease: A pilot longitudinal study
Highlights
► Objective sway measures deteriorated over one year. ► UPDRS motor scores did not show significant changes over one year. ► Medio-lateral (ML) sway measures were more sensitive than antero-posterior sway measures in detecting progression.
Introduction
The defining motor features of Parkinson's disease (PD) are characterized by their insidious onset and inexorable, but variable progression. Reliable and validated, objective markers that can monitor PD progression throughout its course would dramatically improve patient care and accelerate clinical trials [1]. Clinical trials of neuroprotective interventions, in particular, require measures that are able to track PD progression, even in the early stage of the disease and before patients start taking antiparkinsonian medications.
Measures of postural control have not been considered viable candidates for measurement of progression in early-to-moderate, untreated PD because postural problems are not clinically apparent at this stage [2], [3]. In fact, an abnormal response to the Pull test marks the progression from Stage II to Stage III of the Hoehn and Yahr scale and the PIGD (postural instability and gait disorder) subscore of the UPDRS is nearly normal in Stages I and II [3]. Postural problems in patients with PD in clinical trials are usually measured with the PIGD, that includes: sit-to-stand, posture, pull test, and gait evaluated on a 0–4 scale [4], [5]. Although the PIGD is easy to use, does not require equipment, and is quick to administer, the results obtained are subjective and are not sensitive enough to detect early disease progression. Moreover, a recent study that evaluated the responsiveness of different PD scales to change over time showed only a small to moderate effect size of the UPDRS Motor part III [6].
Contrary to the general assumption that postural problems develop later in PD, several recent studies, utilizing force-plate measurements, have shown that postural sway is abnormal early in the disease, even in PD patients with mild symptoms (e.g. Motor UPDRS < 21) [7], [8]. Quantitative measures of postural sway reflect how the nervous system controls the complex sensorimotor task of maintaining bipedal equilibrium [9]. The basal ganglia play an important role in control of axial tone, postural response amplitude, and interpretation of somatosensory information [10], [11], [12]. Thus, postural abnormalities in early PD are not surprising. Although abnormalities in postural sway have been shown to predict past and future falls [13], [14], it is not possible for clinicians to rate measures of postural sway (e.g. sway amplitude, velocity, frequency, or jerkiness), because these are subtle abnormalities that are not always evident or quantifiable by clinical observation.
Our recent studies have shown that neural control of postural sway is compromised in subjects with untreated PD [15] and levodopa administration increases several postural sway parameters [16]. We recently demonstrated that accelerometer-based measures of postural sway can distinguish subjects with untreated PD from age-matched control subjects. Sway jerkiness was shown to be one of the most discriminative measures in differentiating untreated PD from age-matched control subjects. JERK is an indicator of sway smoothness; a higher value indicates more jerky or less smooth sway (i.e. more postural sway corrections). It reflects corrections made by the nervous system to control sway while maintaining a quiet, upright posture.
In the current pilot study, we investigated whether this type of accelerometer-based analysis of spontaneous sway could provide a feasible tool for monitoring progression of postural dyscontrol in people with untreated or newly treated PD. Monitoring progression of postural control with accelerometer-based measures may represent a practical, inexpensive alternative to force plate measures of postural sway because of its unobtrusiveness and portability, key factors for use in clinical or community setting.
Section snippets
Subjects
We followed 13 subjects with idiopathic PD (7 male and 6 female, 60.4 ± 8.5 years) and 12 healthy, age-matched control subjects (5 male and 7 female, 60.2 ± 8.2 years) for 12 months. Control subjects were free of any neurological or musculoskeletal impairment that could affect postural control and were either spouses or friends of subjects with PD. A movement disorders neurologist diagnosed our PD subjects. The PD subjects were free of musculoskeletal disorders and, as inclusion criteria, were not
Changes in sway measures over one year
- •
Trunk accelerations from a representative control subject and an untreated PD subject are shown at baseline, 3–6 m and 12 m in Fig. 1. While traces of the control subject did not change across time, there was a progressive increase in the AP and ML acceleration excursions for the PD subject (P13).
- •
ML sway measures detected more differences between control and PD subjects than the AP sway measures (see Table 2). The ML JERK was significantly larger in the PD group compared to the control group at
Discussion
Results of this pilot longitudinal study suggest that quantitative postural sway measures are able to identify postural dyscontrol early in PD progression and thus may be useful to study progression of Parkinson's disease in early stages of the disease. However, trends toward a slowing in progression of postural sway dyscontrol with initiation of levodopa suggests that more studies are needed to determine if initiation of medication in early PD masks progression of disease.
In this pilot study,
Conflict of interest statement
This research was supported by grants from the Kinetics Foundation and the National Institute on Aging (NIA, 006457). This research was also supported in part by the Intramural Research Program of the NIH. Dr. Horak was a consultant for Kinetics Foundation. This potential conflict of interest has been reviewed and managed by OHSU.
Acknowledgements
We thank all the participants, Triana Nagel for recruiting subjects and data collection assistance, and Edward King for technical assistance. This research was supported by grants from the Kinetics Foundation and the National Institute on Aging (NIA, 006457). This research was also supported in part by the Intramural Research Program of the NIH. Dr. Horak was a consultant for Kinetics Foundation.
References (25)
- et al.
A prospective study of alterations in balance among patients with Parkinson's disease. Protocol of the postural evaluation
European Neurology
(2009) Movement, posture and equilibrium: interaction and coordination
Progress in Neurobiology
(1992)- et al.
Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque
Experimental Neurology
(2007) - et al.
The clinical utility of posturography
Clinical Neurophysiology
(2008) - et al.
Trunk accelerometry reveals postural instability in untreated Parkinson's disease
Parkinsonism Related Disorders
(2011) - et al.
Preferred placement of the feet during quiet stance: development of a standardized foot placement for balance testing
Clinical Biomechanics (Bristol, Avon)
(1997) - et al.
A retrospective analysis of balance control parameters in elderly fallers and non-fallers
Clinical Biomechanics (Bristol, Avon)
(2010) - et al.
Open-loop and closed-loop postural control mechanisms in Parkinson's disease: increased mediolateral activity during quiet standing
Neuroscience Letters
(1995) - et al.
A unified view of quiet and perturbed stance: simultaneous co-existing excitable modes
Neuroscience Letters
(2005) - et al.
Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression
Annals of Neurology
(2008)